Effect of low doses and high homeopathic potencies in normal and cancerous human lymphocytes: an in vitro isopathic study
- PMID: 16813505
- DOI: 10.1089/acm.2006.12.421
Effect of low doses and high homeopathic potencies in normal and cancerous human lymphocytes: an in vitro isopathic study
Abstract
Objectives: Biologic effects of high homeopathic potencies can be studied in cell cultures using cell lines or primary cells. We hypothesized that primary cells would be more apt to respond to high potencies than cell lines, especially cancer cell lines. We set out to investigate the effects of low doses and high homeopathic potencies of cadmium chloride, respectively, in an intoxication model with human primary lymphocytes compared to a human leukemia cell line (Jurkat).
Design: Cells were pretreated with either low concentrations (nM-microM) or high potencies (pool 15-20c) of cadmium for 120 hours, following which they were exposed to a toxic treatment with a range of cadmium concentrations (8-80 microM) during 24 hours. Cell viability was eventually assessed by use of the MTS/PES assay. Controls included a vehicle (NaCl 0.9%) for the low concentrations of cadmium or water 15-20c for cadmium 15-20c. A total of 34 experiments were conducted, 23 with low concentrations and 11 with high potencies of cadmium. Data were analyzed by analysis of variance.
Results: Pretreatment with low concentrations or high potencies of cadmium significantly increased cell viability in primary lymphocytes after toxic challenge, compared to control cells (mean effect +/- standard error = 19% +/- 0.9% for low concentrations respectively 8% +/- 0.6% for high potencies of cadmium; p < 0.001 in both cases). The pretreatment effect of low doses was significant also in cancerous lymphocytes (4% +/- 0.5%; p < 0.001), albeit weaker than in normal lymphocytes. However, high homeopathic potencies had no effect on cancerous lymphocytes (1% +/- 1.9%; p = 0.45).
Conclusions: High homeopathic potencies exhibit a biologic effect on cell cultures of normal primary lymphocytes. Cancerous lymphocytes (Jurkat), having lost the ability to respond to regulatory signals, seem to be fairly unresponsive to high homeopathic potencies.
Similar articles
-
A review of the use and role of low potencies in homeopathy.Complement Ther Med. 2005 Dec;13(4):291-6. doi: 10.1016/j.ctim.2005.10.003. Epub 2005 Nov 16. Complement Ther Med. 2005. PMID: 16338200 Review.
-
Cytotoxicity, zinc protection, and stress protein induction in rat proximal tubule cells exposed to cadmium chloride in primary cell culture.Ren Fail. 1996 Nov;18(6):867-82. doi: 10.3109/08860229609047713. Ren Fail. 1996. PMID: 8948521
-
Evaluating the anticancer activity and nanoparticulate nature of homeopathic preparations of Terminalia chebula.Homeopathy. 2016 Nov;105(4):318-326. doi: 10.1016/j.homp.2016.02.004. Epub 2016 Apr 12. Homeopathy. 2016. PMID: 27914571
-
Cadmium chloride-induced oxidative stress and DNA damage in the human Jurkat T cell line is not linked to intracellular trace elements depletion.Toxicol In Vitro. 2011 Feb;25(1):191-8. doi: 10.1016/j.tiv.2010.10.018. Epub 2010 Oct 30. Toxicol In Vitro. 2011. PMID: 21040778
-
The in vitro evidence for an effect of high homeopathic potencies--a systematic review of the literature.Complement Ther Med. 2007 Jun;15(2):128-38. doi: 10.1016/j.ctim.2007.01.011. Epub 2007 Mar 28. Complement Ther Med. 2007. PMID: 17544864 Review.
Cited by
-
Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner via an immuno-modulatory circuit.BMC Complement Altern Med. 2013 Sep 21;13:230. doi: 10.1186/1472-6882-13-230. BMC Complement Altern Med. 2013. PMID: 24053127 Free PMC article.
-
A homeopathic remedy from arnica, marigold, St. John's wort and comfrey accelerates in vitro wound scratch closure of NIH 3T3 fibroblasts.BMC Complement Altern Med. 2012 Jul 18;12:100. doi: 10.1186/1472-6882-12-100. BMC Complement Altern Med. 2012. PMID: 22809174 Free PMC article.
-
Reporting experiments in homeopathic basic research (REHBaR)--a detailed guideline for authors.Homeopathy. 2009 Oct;98(4):287-298. doi: 10.1016/j.homp.2009.09.006. Homeopathy. 2009. PMID: 19945681 Free PMC article.
-
The emerging low-dose therapy for advanced cancers.Dose Response. 2009 Mar 24;7(3):208-20. doi: 10.2203/dose-response.08-010.Satti. Dose Response. 2009. PMID: 19809540 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
